EU antitrust regulators cleared Pfizer's proposed $68-billion merger with Wyeth on the condition that Pfizer carry through with its commitments to divest certain animal health assets in the EU. Officials noted that the companies' activities with regard to human health are largely complementary.
Full story
No comments:
Post a Comment